The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs.

The Supreme Court on Monday punted on a fight over the ability of voters to bring Voting Rights Act lawsuits, dodging a major dispute over the landmark civil rights law that the conservative majority had already left on life support with a previous ruling this term.